Elevated levels of basic fibroblast growth factor in the urine of clam enterocystoplasty patients.
OBJECTIVE
We determined whether basic fibroblast growth factor is elevated in the urine of patients who have undergone clam ileocystoplasty.


METHODS
An immunoassay technique was used to measure urinary basic fibroblast growth factor in 50 patients equally divided between those with and without neuropathy who had undergone clam enterocystoplasty. The results were compared with urinary basic fibroblast growth factor concentrations from 25 healthy age and sex matched volunteers.


RESULTS
There is a highly significant elevation of urinary basic fibroblast growth factor in clam enterocystoplasty patients compared to controls, which is not related to the presence or absence of infection. There is no difference between those with and without neuropathy.


CONCLUSIONS
Elevated levels of basic fibroblast growth factor are an important consideration in the malignant potential of the clam procedure.
Barrington
J W
JW
Department of Urology, Cardiff Royal Infirmary and Research Laboratories, Velindre NHS Trust Hospital, South Glamorgan, United Kingdom.
Fraylin
L
L
Fish
R
R
Shelley
M
M
Stephenson
T P
TP
D000293:Adolescent; D000328:Adult; D016022:Case-Control Studies; D002648:Child; D005260:Female; D016222:Fibroblast Growth Factor 2 / Q000652:urine*; D006801:Humans; D007082:Ileum / Q000637:transplantation*; D008297:Male; D008875:Middle Aged; D011184:Postoperative Period; D001743:Urinary Bladder / Q000601:surgery*
D016222:Fibroblast Growth Factor 2